These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1832344)

  • 1. Comparison of the effects of ANF 99-126 and ANF 103-126 on captopril-induced renin release in man.
    Lang CC; McMurray JJ; Moyses C; Struthers AD
    Clin Endocrinol (Oxf); 1991 Jun; 34(6):493-9. PubMed ID: 1832344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of angiotensin converting enzyme inhibition and atrial natriuretic factor.
    Richards AM; Rao G; Espiner EA; Yandle T
    Hypertension; 1989 Mar; 13(3):193-9. PubMed ID: 2537795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of low dose infusion of atrial natriuretic factor on acute inhibition of angiotensin converting enzyme in normal man.
    Nakamura M; Arakawa N; Kawata Y; Kato M
    Clin Exp Pharmacol Physiol; 1990 Jan; 17(1):17-22. PubMed ID: 2140961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial natriuretic factor attenuates prostaglandin E2-stimulated plasma renin activity in humans.
    McMurray J; McFarlane L; Coutie W; Balfour D; Struthers A
    J Cardiovasc Pharmacol; 1989 Aug; 14(2):326-30. PubMed ID: 2476609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Captopril enhances renal responsiveness to ANF in dogs with compensated high-output heart failure.
    Villarreal D; Freeman RH; Johnson RA
    Am J Physiol; 1992 Mar; 262(3 Pt 2):R509-16. PubMed ID: 1313653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal and vascular effects of atrial natriuretic factor during cardiopulmonary bypass.
    Hynynen M; Palojoki R; Heinonen J; Tikkanen I; Harjula AL; Fyhrquist F
    Chest; 1991 Nov; 100(5):1203-9. PubMed ID: 1834440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril.
    Bralet J; Marie C; Mossiat C; Lecomte JM; Gros C; Schwartz JC
    J Pharmacol Exp Ther; 1994 Jul; 270(1):8-14. PubMed ID: 8035346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of atrial natriuretic factor infusion on basal and CRH-stimulated ACTH, cortisol and aldosterone levels in patients with Cushing's or Addison's disease.
    Ambrosi B; Sala C; Bochicchio D; Colombo P; Gazzano G; Fadin C; Morganti A; Faglia G
    Clin Endocrinol (Oxf); 1994 May; 40(5):589-94. PubMed ID: 8013139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of incremental infusions of atrial natriuretic factor on aldosterone, renin, and blood pressure in humans.
    Oelkers W; Kleiner S; Bähr V
    Hypertension; 1988 Oct; 12(4):462-7. PubMed ID: 2971619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of angiotensin-converting enzyme inhibition on plasma brain natriuretic peptide levels in patients with heart failure.
    Lang CC; Motwani JG; Rahman AR; Coutie WJ; Struthers AD
    Clin Sci (Lond); 1992 Aug; 83(2):143-7. PubMed ID: 1327628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An atrial natriuretic factor analogue at low doses attenuates forearm reflex vasoconstriction to cardiopulmonary receptor deactivation in patients with hypertension.
    Pedrinelli R; Taddei S; Favilla S; Simonini N; Spessot M; Panarace G; Salvetti A
    Am Heart J; 1991 Mar; 121(3 Pt 1):840-7. PubMed ID: 1825739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial natriuretic factor inhibits metoclopramide stimulated aldosterone release in man.
    Lang CC; Rahman AR; Struthers AD
    Br J Clin Pharmacol; 1991 Jul; 32(1):51-6. PubMed ID: 1832287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aldosterone and renin inhibition by physiological levels of atrial natriuretic factor.
    Brands MW; Freeman RH
    Am J Physiol; 1988 Jun; 254(6 Pt 2):R1011-6. PubMed ID: 2968054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of plasma endothelin-1 level by alpha-human atrial natriuretic peptide and angiotensin converting enzyme inhibition in normal men.
    Uemasu J; Matsumoto H; Kitano M; Kawasaki H
    Life Sci; 1993; 53(11):969-74. PubMed ID: 8366764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged low dose infusion of atrial natriuretic factor in essential hypertension.
    Cusson JR; Thibault G; Cantin M; Larochelle P
    Clin Exp Hypertens A; 1990; 12(1):111-35. PubMed ID: 2155074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired aldosterone production by long-term infusion of atrial natriuretic factor.
    Nagano M; Bravo EL
    Am J Physiol; 1990 Jan; 258(1 Pt 1):E51-6. PubMed ID: 2137294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of atrial natriuretic factor [alpha-human ANF-(99-126)] in the hormonal and renal adaptation to sodium deficiency.
    Beland B; Tuchelt H; Bähr V; Oelkers W
    J Clin Endocrinol Metab; 1994 Jul; 79(1):183-8. PubMed ID: 8027224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of atrial natriuretic factor on pressor responsiveness to angiotensin II, norepinephrine, and vasopressin in conscious sheep.
    Parkes DG; Coghlan JP; McDougall JG; Scoggins BA
    J Cardiovasc Pharmacol; 1990 Jan; 15(1):16-21. PubMed ID: 1688975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Captopril reduces the renal response to intravenous atrial natriuretic peptide in normotensives.
    Wilkins MR; Lewis HM; West MJ; Kendall MJ; Lote CJ
    J Hum Hypertens; 1987 Jun; 1(1):47-51. PubMed ID: 2977404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-dependent vasodilation of the skin microcirculation by atrial natriuretic factor.
    Jansen TL; Tan AC; Wollersheim H; Benraad TJ; Thien T
    J Cardiovasc Pharmacol; 1991 Oct; 18(4):622-30. PubMed ID: 1724541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.